Search Results 151-160 of 8547 for 78%

  1. Class Profile - M.D. Program - Mayo Clinic Alix School of Medicine

    Mathematics. 23%. underrepresented in medicine relative to their numbers in the general population. 3.94. median cumulative GPA. 78. students with gap years ...

  2. pain medication Archives - Mayo Clinic News Network

    , Minn. — Each day, 78 people in the U.S. die of opioid overdoses, and more than 1,000 are treated in emergency departments for opioid misuse, federal ...

  3. Health Topics - Mayo Clinic News Network

    78 · 79 · 80 · 81 · 82 · 83 · 84 ... Next · Last. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery Science · Healthcare ...

  4. Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular Age-related Macular Degeneration (PANDA-1) - Mayo Clinic

    Have a ETDRS BCVA letter score of 78 to 25 in the study eye at Screening; 6. Are willing and able to sign the study written informed consent form (ICF) ...

  5. Laboratories - Mayo Clinic Research

    C. Cancer Biology and Translational Research: John A. Copland III · Cancer Research and Cellular Therapies: Januario E. Castro · Cardiovascular Disease and ...

  6. Publications

    2003 Nov; 143: (5)609-13. View PubMed; El-Youssef M. Wilson disease. Mayo Clin Proc. 2003 Sep; 78 (9):1126-36. View PubMed; Rossetti S, Torra R, Coto E ...

  7. A Study to Develop A Family Registry to Collect Alzheimer's Biomarkers - Mayo Clinic

    Apr; 41(4):469-78. We compare clinicopathologic data from 10 subjects identified in the very mild stage of senile dementia of the Alzheimer type with ...

  8. A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM - Mayo Clinic

    Patients must be between the ages of 18 and 78 years. Patient must have a signed study informed consent prior to entering the study. Histologically ...

  9. A Study to Assess Older Adults Applying Pre-transplant Comorbidity, Geriatric Assessment and Biomarkers to Predict Non-Relapse Mortality After Allogeneic Transplant (CHARM) - Mayo Clinic

    ... (78%, 64%, and 51%, respectively), although they were higher than after UD transplantation (51% [P = .08], 38% [P = .02], and 31% [P = .007]). We conclude ...

  10. Treatment for CI-DME in Eyes With Very Good VA Study - Mayo Clinic

    ... 78 or worse (approximate Snellen equivalent of 20/32 or worse) were eligible. Eyes that have central-involved DME with "good" visual acuity (20/25 or better) ...